Ondansetron HCl 2mg Injection (per ml) — Liquid Injections
WHO-GMP Certified Commercial Pack · Product Code: AKP-058

Ondansetron HCl 2mg Injection (per ml)

Formulation Overview: Selective 5-HT3 serotonin receptor antagonist parenteral antiemetic acting at both chemoreceptor trigger zone and vagal nerve terminals for rapid surgical and emergency emesis arrest. Formulated with Ondansetron Hydrochloride IP (eq. Ondansetron 2 mg per ml) (2 mg / 1 ml (4 mg / 2 ml pack)) in Sterile Liquid Injection Ampoule dosage form under Gastroenterology & PPIs, manufactured to IP / BP / USP Compendial standards and supplied in 10 x 2 ml Clear USP Type I Glass Ampoules with complete eCTD/ACTD regulatory dossiers, Zone IVb stability, and batch CoA for African NRAs (NAFDAC, PPB, SAHPRA, TMDA, FDA Ghana) and global tenders.
Item Code (SKU)AKP-058
Therapeutic SectorGastroenterology & PPIs
Dosage FormSterile Liquid Injection Ampoule
Active IngredientOndansetron Hydrochloride IP (eq. Ondansetron 2 mg per ml)
Strength / Purity2 mg / 1 ml (4 mg / 2 ml pack)
Clinical IndicationPost-operative nausea and vomiting (PONV), chemotherapy-induced emesis, and acute refractory gastroenteritis vomiting
Specification StandardIP / BP / USP Compendial
Packaging Format10 x 2 ml Clear USP Type I Glass Ampoules
Shelf Life24–36 Months
Storage ConditionsStore below 25°C; protect from light; do not freeze
Minimum Order Quantity1000 Packs
Regulatory / Analytical DocsFull eCTD / ACTD Modules 1–5 + Zone IVb Stability Available
African & Global NRA ReadinessNAFDAC (Nigeria), PPB (Kenya), SAHPRA (SA), TMDA (Tanzania), FDA Ghana, AIRP, ARP, EFDA
Stock AvailabilityIn Stock · Immediate Commercial Dispatch
Supply StatusCommercial Export Ready

Related Liquid Injections & Gastroenterology & PPIs